13F-HR filed by Boxer Capital, LLC
Boxer Capital, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 71 holding rows worth $1,896,920,313.
- Accession
- 0000895345-23-000135
- Filer
- CIK 1465837
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 71 entries on the cover page, a total value of $1,896,920,313 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,896,920,313 with VALUE read as dollars as filed, 13F file number 028-17339. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 1,897,500 | $208,725,000 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 500,000 | $109,970,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 2,100,000 | $96,222,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 3,984,264 | $94,905,168 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 2,000,000 | $90,620,000 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 3,421,541 | $88,994,281 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 1,576,000 | $81,494,960 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 2,084,000 | $77,003,800 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 7,123,642 | $51,646,405 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 6,448,359 | $49,007,528 | dollars as filed | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 1,230,004 | $46,727,852 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 831,495 | $45,565,926 | dollars as filed | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 2,154,058 | $42,068,752 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 1,094,000 | $41,725,160 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 1,300,000 | $40,287,000 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 2,202,812 | $40,025,094 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,251,137 | $38,785,245 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 1,210,192 | $36,039,518 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 2,169,132 | $32,406,832 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 400,000 | $30,852,000 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 1,432,200 | $29,617,896 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 1,900,000 | $29,393,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,466,051 | $28,690,618 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 2,325,000 | $28,388,250 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 850,000 | $27,871,500 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 3,163,795 | $27,525,016 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 3,200,000 | $26,304,000 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 1,189,943 | $25,607,573 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 1,121,327 | $24,882,246 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 600,000 | $23,658,000 | dollars as filed | |
| GERON CORP | 374163103 | COM | 8,100,000 | $19,602,000 | dollars as filed | |
| EXELIXIS INC COM | 30161Q104 | Stock | 1,150,000 | $18,446,000 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 2,500,000 | $18,225,000 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 300,000 | $18,075,000 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 1,400,000 | $17,822,000 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 825,000 | $17,663,250 | dollars as filed | |
| RAIN ONCOLOGY INC | 75082Q105 | COM | 2,147,212 | $17,177,696 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,500,000 | $14,100,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 1,224,892 | $13,449,314 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 1,250,000 | $12,612,500 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 95,000 | $11,602,350 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,074,082 | $11,331,565 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,505,133 | $9,617,800 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,054,000 | $7,362,401 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 3,336,928 | $7,241,134 | dollars as filed | |
| PANACEA ACQUISITION CORP II | G6882C106 | COM | 500,000 | $6,208,060 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 525,000 | $6,069,000 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 686,347 | $5,662,363 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 150,000 | $5,131,500 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 540,000 | $4,995,000 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 459,836 | $4,308,663 | dollars as filed | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 3,284,072 | $3,711,001 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 2,014,858 | $3,626,744 | dollars as filed | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 510,000 | $3,111,000 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 698,861 | $2,767,490 | dollars as filed | |
| NGM BIOPHARMACEUTICALS INC | 62921N105 | COM | 500,000 | $2,510,000 | dollars as filed | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 250,000 | $2,495,000 | dollars as filed | |
| EQRX INC | 26886C107 | COM | 1,000,000 | $2,460,000 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 570,417 | $2,452,793 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 1,450,000 | $2,218,500 | dollars as filed | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 415,000 | $2,066,700 | dollars as filed | |
| Veru Inc | 92536C103 | Common Stock | 347,300 | $1,833,744 | dollars as filed | |
| ATRECA INC | 04965G109 | COM | 2,202,333 | $1,763,188 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 2,250,000 | $1,687,500 | dollars as filed | |
| ZIOPHARM ONCOLOGY INC | 98973P101 | COM | 1,500,000 | $973,650 | dollars as filed | |
| MEI PHARMA INC | 55279B202 | COM NEW | 2,913,091 | $709,629 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 209,227 | $560,728 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 130,000 | $175,500 | dollars as filed | |
| BELLICUM PHARMACEUTICALS INC COM NEW | 079481404 | Stock | 56,950 | $41,004 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 266,666 | $38,533 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 66,666 | $4,393 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000895345-23-000135 | this filing | 2023-02-14 | acceptance time not in the bulk data set |